do you gain weight back after semaglutide Regain Semaglutide: What Research Shows In the original clinical trials

And in most cases, the benefits outweigh the costs

Human Data: Mixed Early Signals Realworld analyses and observational studies have also hinted that people taking GLP1 drugs for diabetes or weight loss may have a lower risk of dementia, including Alzheimers, compared with users of other diabetes medicines

Oral Wegovy (Semaglutide Pill) Introduced in December 2025, the oral version of Wegovy offers an accessible alternative for those who prefer pills over injections

What Patients Typically Notice As GLP 1 signaling increases, food cues and eating patterns often begin to shift in subtle but meaningful ways

Here is how the math works out using the standard titration schedule

Finally, GLP-1s affect both insulin and glucagon release